Washington, DC - Two providers of ambulance services have agreed to divest inter-facility air ambulance transport services in Hawaii to settle Federal Trade Commission charges that their proposed merger would likely harm competition among air ambulance transport services that transfer patients between medical facilities on different Hawaiian islands.

Washington, DC - The Federal Trade Commission and the Federal Communications Commission today announced two upcoming events aimed at furthering the fight against illegal robocalls and caller ID spoofing. The agencies will co-host a Policy Forum later this month and a Technology Expo in April.

Washington, DC - The Department of Justice’s Antitrust Division will hold a series of three public roundtable discussions to explore the relationship between competition and regulation, and its implications for antitrust enforcement policy. The first roundtable will occur on Wednesday, March 14, 2018 in the Great Hall of the Robert F. Kennedy Department of Justice Building, 950 Pennsylvania Avenue, NW, Washington, D.C. from 10:00 a.m. to 1:00 p.m. EST. The tentative agenda of the first roundtable can be found below.

Washington, DC - The U.S. Food and Drug Administration today approved the Imugen Babesia microti Arrayed Fluorescent Immunoassay (AFIA), for the detection of antibodies to Babesia microti (B. microti) in human plasma samples, and the Imugen Babesia microti Nucleic Acid Test (NAT), for the detection of B. microti DNA in human whole blood samples. These tests are intended to be used as donor screening tests on samples from individual human donors, including volunteer donors of whole blood and blood components, as well as living organ and tissue donors.

Washington, DC - Oklahoma Governor Mary Fallin and Transportation Secretary Mike Patterson: “Trump’s infrastructure plan brings needed attention for improvements”.